Create a free research account to view current pricing and place an order.
Mechanism of action
Thymosin Alpha-1 is an immune-modulating thymic peptide researched for T-cell signaling, dendritic-cell activity, innate/adaptive immune coordination, and host-defense pathway support.
Half-life & pharmacokinetics
Half-life: Short-to-moderate; clinical context dependent.
Human clinical formulations have immune-modulatory dosing schedules; research preparations vary. Functional immune signaling may persist beyond plasma exposure.
Research dosing reference
0.3-1.6 mg daily or several times weekly depending on immune protocol objective.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 0.3 mg | 6 units |
| 1.0 mg | 20 units |
| 1.6 mg | 32 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Often administered several times weekly or daily in structured immune protocols.
Beginner escalation
Begin conservatively and monitor immune/inflammatory response.
Side-effect mitigation
Monitor injection irritation, flu-like feelings, fatigue, immune flares, or headache.
Stack compatibility
Pairs with immune-support frameworks; avoid combining with many immune-active peptides at initiation.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Common immune-support courses often use several-week blocks with marker/symptom reassessment before repeating or extending. Hormonal / Miscellaneous
Frequently asked questions
What is Thy Alpha 1 and how does it work?
Thymosin Alpha-1 is an immune-modulating thymic peptide researched for T-cell signaling, dendritic-cell activity, innate/adaptive immune coordination, and host-defense pathway support.
What is the half-life of Thy Alpha 1?
Thy Alpha 1: Short-to-moderate; clinical context dependent. Human clinical formulations have immune-modulatory dosing schedules; research preparations vary. Functional immune signaling may persist beyond plasma exposure.
How is Thy Alpha 1 reconstituted for research?
Preferred reconstitution for the 10 mg vial is 2 mL BAC Water, giving 0.050 mg/unit. Always confirm concentration math before any use. Research use only.
Is Thy Alpha 1 FDA approved?
No. Thy Alpha 1 is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration